Feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 7, 2013, Pages 885-891

  Darda, Saba ^a   Khouri, Yazan ^a   Gorges, Rony ^a   Al Samara, Mershed ^a   Jain, Sachin K Amruthlal ^a   Daccarett, Marcos ^a   Machado, Christian ^a  

^a PROVIDENCE HOSPITAL   (United States)

Author keywords

discharge; implantable cardioverter defibrillator; safety; same day

Indexed keywords

ACETYLSALICYLIC ACID; CEFAZOLIN; CLINDAMYCIN; CLOPIDOGREL; HEMOGLOBIN; WARFARIN;

ADULT; AGED; ARTICLE; CARDIAC CHAMBER PERFORATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY SINUS PERFORATION; DEVICE INFECTION; DEVICE MALFUNCTION; FEASIBILITY STUDY; FEMALE; FEVER; FOLLOW UP; HEART ARREST; HEART INFARCTION; HEART INJURY; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MEDICAL RECORD REVIEW; OPERATIVE BLOOD LOSS; OUTPATIENT; PNEUMOTHORAX; PRIMARY PREVENTION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SUDDEN CARDIAC DEATH; SWELLING; TRICUSPID VALVE INJURY; WOUND COMPLICATION;

DISCHARGE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; SAFETY; SAME DAY;

AGED; AMBULATORY CARE; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MICHIGAN; MIDDLE AGED; PATIENT DISCHARGE; PATIENT SAFETY; POSTOPERATIVE COMPLICATIONS; PRIMARY PREVENTION; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84879691095     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12145     Document Type: Article

References (25)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
2. Goldberger Z, Lampert R,. Implantable cardioverter-defibrillators: Expanding indications and technologies. JAMA 2006; 295: 809-818.
3. Sanders GD, Hlatky MA, Owens DK,. Cost-effectiveness of implantable cardioverter defibrillators. N Engl J Med 2005; 353: 1471-1480.
4. Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenrich PA, Dembitzer AD, Hlatky MA,. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of Sudden cardiac death. Ann Intern Med 1997; 126: 1-12.
5. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA,. The relation between hospital procedure volume and complications of cardioverter-defibllator from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2010; 56: 1133-1139.
6. Zhan C, Baine WB, Sedrakyan A, Steiner C,. Cardiac devise implantation in the United States from 1997 through 2004: A population-based analysis. J Gen Intern Med 2007; 23: 13-19.
7. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, et al. Detection and management of an implantable cardioverter defibrillator lead failure: Incidence and clinical implications. J Am Coll Cardiol 2003; 41: 73-80.
8. Kleeman T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007; 115: 2474-2480.
9. Tisseau A, Fauchier L, Poret P, Robin I, Cosnay P, Babuty D,. Evalution of the cost of complications of automatic implantable defibrillators. Arch Mal Coeur Vaiss 2007; 100: 736-744.
10. Uslan DZ, Baddour LM,. Caridac device infections: Getting to the heart of the matter. Curr Opin Infect Dis 2006; 19: 345-348.
11. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
12. Mela T, McGovern BA, Garan H, Vlahakes GJ, Torchiana DF, Ruskin J, Galvin JM,. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibillator implants. Am J Cardiol 2001; 88: 750-753.
13. Da Costa A, Lelievre H, Kirkorian G, Celard M, Chevalier P, Vandenesch F, Etienne J, et al. Role of preaxillary flora in pacemaker infections: A prospective study. Circulation 1998; 97: 1791-1795.
14. Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, Mahon N, et al. Contemporary management of and outcomes form cardiac device related infections. Europace 2010; 12: 64-70.
15. Catanchin A, Murdock CJ, Athan E,. Pacemaker infections: A 10-year experience. Heart Lung Circ 2007; 16: 434-439.
16. Laborderie J, Barandon L, Ploux S, Deplagne A, Mokrani B, Reuter S, Le Gal F, et al. Mangement of subacute and delayed right ventricular perforation with a pacing or and implantable cardioverter-defibrillator lead. Am J Cardiol 2008; 102: 1352-1355.
17. Rosenqvist M, Beyer T, Block M, Den Dulk K, Minten J, Lindemans F,. Adverse events with transvenous implantable cardioverter-defibrillators: A prospective multicenter study. Circulation 1998; 98: 663-670.
18. Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE,. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 2005; 46: 1536-1540.
19. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 2009; 301: 1661-1670.
20. Kron J, Herre J, Renfroe EG, Rizo-Patron C, Raitt M, Halperin B, Gold M, et al. Lead- and devise-related complications in the antiarrhythmics versus implantable defibrillatiors trial. Am Heart J 2001; 141: 92-98.
21. Gold MR, Peters RW, Johnson JW, Shorlfsky SR,. Complications associated with pectoral cardioverter-defibrillator implantation: Comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol 1996; 28: 1278-1282.
22. Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ,. Implantable cardiac device procedures in older patients. Arch Intern Med 2010; 170: 631-637.
23. Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA, National Cardiovascular Data Registry. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 2009; 6: 1565-1571.
24. Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, et al. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 2010; 55: 2376-2382.
25. Choudhuri I, Desai D, Walburg J, August P, Keller SI, Suri R,. Feasibility of early discharge after implantable cardioverter-defibrillator procedures. J Cardiovasc Electrophysiol 2012; 23: 1123-1129.